The Effect of Prebiotic Synergy1 Supplementation on Microbiota, Protein Metabolism and Gastrointestinal (GI) Symptoms in People Consuming High Protein Diet
NCT02827760 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2021-05-06
Summary
The composition and metabolism of human gut microbiota play crucial roles in health. Microbial colonisation of the gastrointestinal tract varies widely, with the large intestine having not only the highest density of microbes in terms of bacterial cells per gram but also the most metabolically active microbial community. Genetics, mode of birth, infant feeding patterns, antibiotic usage, sanitary living conditions and long term dietary habits contribute towards shaping the composition of the gut microbiome. Diet clearly has a major impact on variation in the gut microbiota composition, and this can be detected in faecal samples after only a few days. The bacterial metabolism of dietary components produces much chemical diversity in the large intestine with protective or detrimental effects on disease development.
Dietary protein levels are relatively high in western European populations, up to 103g/d, as reported by Food and Agriculture Organization. This may result in high levels, entering the large gut where it can become a substrate for proteolytic bacteria. Protein specifically can provide nutrition for microorganisms but metabolites from bacterial protein breakdown can be detrimental. Protein intake from the diet might not be the only source of microbial proteolysis; the human body also secretes considerable amounts of protein into the digestive lumen which can potentially be used by the microflora. On the contrary, end products of carbohydrate metabolism can be positive for health. In this context, prebiotics are carbohydrates that are resistant to digestion and can become available for bacteria in the colon to produce short chain fatty acids and inhibit the production of harmful metabolites. A switch towards more carbohydrate metabolism in the colon, at the expense of proteolysis therefore has positive capacity through the production of more benign metabolites.
Rationale for design Prebiotics are dietary ingredients that target carbohydrate digesting bacteria only. Given the high intake levels of protein in Western populations, they may be useful to modulate the composition/activity of the microbial gut ecology for improved health.
Among prebiotic nutrients, inulin-type fructans (ITF) are well characterized and their administration promotes growth of beneficial microorganisms like Bifidobacterium spp. .These microorganisms are involved in the reduction of intestinal endotoxin concentration, improve glucose tolerance, exert benefits upon immune function and inhibit pathogens. In healthy individuals, ITF intake promotes satiety and modulates gut peptides regulating food intake.
The aim of the present study is to investigate the effect of inulin-type fructans (ITF) on the negative consequences of colonic fermentation in individuals consuming high protein diets. The hypothesis to be tested is that their action promotes carbohydrate degrading bacteria at the expense of protein utilisers.
Conditions
- Gut Microbiota
Interventions
- DIETARY_SUPPLEMENT
-
Synergy1
Inulin type fructans
- DIETARY_SUPPLEMENT
-
Maltodextrin
Sponsors & Collaborators
-
University of Reading
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Synbiotic Dietary Supplement and Gut Microbiota
NCT04097106 ·Status: COMPLETED
-
The Effects of a High Protein Diet on Microbiota, Gastrointestinal Function and Wellness in Older Women
NCT02445560 ·Status: COMPLETED ·Phase: NA
-
Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis
NCT06615986 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Use of a Selected Mixture of Probiotic Strains for Degrading Gluten During Digestion
NCT05798689 ·Status: COMPLETED ·Phase: NA
-
Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults
NCT02355210 ·Status: COMPLETED ·Phase: NA
-
Multistrain Probiotic for Functional Constipation
NCT01618617 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Synbiotic Approach to Immunity and Metabolism in the Elderly Study
NCT03168503 ·Status: COMPLETED ·Phase: NA
-
A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth
NCT07215676 ·Status: COMPLETED ·Phase: NA
-
Prebiotic Intervention for Autism Spectrum Disorders
NCT02720900 ·Status: COMPLETED ·Phase: NA
-
Precision Probiotic Supplementation in Individuals With Mild Cognitive Impairment
NCT06278688 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Prebiotics on Endurance Performance
NCT04946578 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms
NCT05845073 ·Status: COMPLETED ·Phase: NA
-
Capture of Healthy Gut Bacteria Associated to High Fiber Diet
NCT06166810 ·Status: RECRUITING
-
Determination of the Safety and Efficacy of Two Probiotic Strains
NCT06466174 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk
NCT04232852 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Probiotics on Blood Pressure Management
NCT03973710 ·Status: SUSPENDED ·Phase: NA
-
Effect of a Nutritional Supplement on Gut Microbiota in Adults
NCT06611215 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Probiotic Against Functional Constipation
NCT06122558 ·Status: RECRUITING ·Phase: PHASE2
-
Adult HMO Supplementation and the Gut Microbiome
NCT06570330 ·Status: COMPLETED ·Phase: NA
-
Probiotics Use in the Chronic Peritoneal Dialysis Patients
NCT01076426 ·Status: UNKNOWN ·Phase: PHASE4
-
Development and Evaluation of Functional Probiotic Powder in Human Trials
NCT06760468 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diet Supplementation With Prebiotics to Improve Gut Health in Egyptian Children
NCT06561724 ·Status: RECRUITING ·Phase: NA
-
Effect of The Substitution of Animal Protein by Soya-Based Fermented Product on Human Gut Microbiome
NCT06304480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of a Synbiotic Formula in Patient With COVID-19
NCT04730284 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Synbiotics on the Upper Respiratory Tract Infection
NCT04960878 ·Status: COMPLETED ·Phase: NA